Literature DB >> 28066560

Targeting tumorigenicity of breast cancer stem-like cells using combination epigenetic therapy: something old and something new.

Yi Huang1, Nancy E Davidson2.   

Abstract

Entities:  

Year:  2016        PMID： 28066560      PMCID： PMC5179425          DOI： 10.21037/jtd.2016.11.18

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

Review 1.  Epigenetic regulation as a new target for breast cancer therapy.

Authors:  Vered Stearns; Qun Zhou; Nancy E Davidson
Journal:  Cancer Invest       Date:  2007-12       Impact factor: 2.176

Review 2.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

3.  Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.

Authors:  Dipali Sharma; Neeraj K Saxena; Nancy E Davidson; Paula M Vertino
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 4.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

5.  Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.

Authors:  Rajneesh Pathania; Sabarish Ramachandran; Gurusamy Mariappan; Priyanka Thakur; Huidong Shi; Jeong-Hyeon Choi; Santhakumar Manicassamy; Ravindra Kolhe; Puttur D Prasad; Suash Sharma; Bal L Lokeshwar; Vadivel Ganapathy; Muthusamy Thangaraju
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

6.  Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.

Authors:  Vered Stearns; Lisa K Jacobs; Maryjo Fackler; Theodore N Tsangaris; Michelle A Rudek; Michaela Higgins; Julie Lange; Zandra Cheng; Shannon A Slater; Stacie C Jeter; Penny Powers; Susanne Briest; Calvin Chao; Carl Yoshizawa; Elizabeth Sugar; Igor Espinoza-Delgado; Saraswati Sukumar; Edward Gabrielson; Nancy E Davidson
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

7.  Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.

Authors:  Madhavi Billam; Michele D Sobolewski; Nancy E Davidson
Journal:  Breast Cancer Res Treat       Date:  2009-05-21       Impact factor: 4.872

8.  The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.

Authors:  Marion A Salvador; Julien Wicinski; Olivier Cabaud; Yves Toiron; Pascal Finetti; Emmanuelle Josselin; Hélène Lelièvre; Laurence Kraus-Berthier; Stéphane Depil; François Bertucci; Yves Collette; Daniel Birnbaum; Emmanuelle Charafe-Jauffret; Christophe Ginestier
Journal:  Clin Cancer Res       Date:  2013-10-18       Impact factor: 12.531

Review 9.  DNA methylation profiling in the clinic: applications and challenges.

Authors:  Holger Heyn; Manel Esteller
Journal:  Nat Rev Genet       Date:  2012-09-04       Impact factor: 53.242

Review 10.  Epigenetics in breast cancer: what's new?

Authors:  Yi Huang; Shweta Nayak; Rachel Jankowitz; Nancy E Davidson; Steffi Oesterreich
Journal:  Breast Cancer Res       Date:  2011-11-01       Impact factor: 6.466
View more
  4 in total

Review 1.  Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Rosa Drago-Ferrante; Yashwanth Subbannayya; Francesca Pentimalli; Antonio Giordano; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via ERK/JNK Pathway.

Authors:  Jianghong Cheng; Mingli Li; Chi-Meng Tzeng; Xingchun Gou; Shuai Chen
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

Review 3.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

4.  Aberrant methylation of WD-repeat protein 41 contributes to tumour progression in triple-negative breast cancer.

Authors:  Han Wang; Dan Wu; Liangliang Cai; Xiaohong Li; Zhiming Zhang; Shuai Chen
Journal:  J Cell Mol Med       Date:  2020-05-12       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.